# Antidepressant Medication Plus Donepezil for Treating Late-life Depression

> **NCT00177671** · PHASE4 · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 220 (actual)

## Conditions studied

- Depression
- Dementia

## Interventions

- **DRUG:** Escitalopram
- **DRUG:** Donepezil
- **DRUG:** Venlafaxine
- **DRUG:** Placebo
- **DRUG:** Duloxetine

## Key facts

- **NCT ID:** NCT00177671
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2013-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00177671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00177671, "Antidepressant Medication Plus Donepezil for Treating Late-life Depression". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00177671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*